secwatch.observer — SEC 8-K summary
======================================

Issuer:     Immunome Inc. (IMNM)
CIK:        0001472012
Form:       8-K
Filed at:   2023-11-08T23:59:59+00:00
Accession:  0001104659-23-115534
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Immunome appoints Jean-Jacques Bienaimé as Class II director; initial option grant of $270K
--------------------------------------------------------------------------------

- Jean-Jacques Bienaimé appointed as Class II director effective Nov 7, 2023, term through 2025 annual meeting.
- Appointed to Audit, Compensation, and Nominating & Corporate Governance Committees.
- Receives annual cash retainers totaling $57,500 ($40K board, $7.5K audit, $5K each for comp and nominating).
- Granted initial option with Black-Scholes value of $270K vesting quarterly over three years.
- Eligible for automatic annual option grants of $135K at each annual meeting, vesting over 12 months.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1472012/000110465923115534/0001104659-23-115534-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1472012/000110465923115534/tm2330142d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-115534

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer